Can mirtazapine (Remeron) be taken concomitantly with clozapine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Mirtazapine (Remeron) Be Taken with Clozapine?

Yes, mirtazapine can be safely taken with clozapine, and this combination may provide therapeutic benefits for negative symptoms and cognitive dysfunction in schizophrenia. The FDA drug label for Remeron does not list clozapine as a contraindicated or cautioned combination, and multiple clinical studies demonstrate both safety and potential efficacy of this augmentation strategy 1.

Safety Profile of the Combination

The pharmacokinetic interaction between mirtazapine and clozapine is negligible. A study of 24 patients with chronic schizophrenia found that adding mirtazapine 30 mg daily to clozapine (200-650 mg/day) produced only minimal and statistically insignificant changes in clozapine plasma concentrations 2. This means mirtazapine does not meaningfully alter clozapine levels, eliminating concerns about toxicity or loss of efficacy due to drug-drug interactions.

The combination was well-tolerated across multiple studies, with no serious adverse events reported specifically attributable to the drug interaction 2, 3, 4.

Potential Clinical Benefits

Mirtazapine augmentation of clozapine may improve negative symptoms and cognitive function in patients with schizophrenia:

  • Negative symptoms: A double-blind, placebo-controlled trial demonstrated significant reduction in Scale for Assessment of Negative Symptoms (SANS) total scores (p<0.01), with particular improvement in avolition/apathy and anhedonia/asociality subscales 4

  • Cognitive enhancement: An 8-week open-label trial showed significant improvement in cognitive performance measured by RBANS total score and immediate/delayed memory subscales (p<0.01) 3. Importantly, these cognitive improvements appeared to be direct effects rather than secondary to mood improvement.

  • Treatment-resistant cases: A systematic review and network meta-analysis ranked mirtazapine as one of the top three augmentation strategies for clozapine-resistant schizophrenia, alongside ECT and memantine 5

Practical Prescribing Considerations

When combining these medications, monitor for:

  • Additive sedation: Both drugs cause sedation; mirtazapine is particularly sedating 6, 7. Dose at bedtime and counsel patients about daytime drowsiness.

  • Weight gain: Both clozapine and mirtazapine are associated with significant weight gain 8. Mirtazapine causes approximately 1.5 kg weight gain on average 8. Consider prophylactic metformin with clozapine 9.

  • QTc prolongation: The FDA label cautions about using mirtazapine with other QTc-prolonging drugs 1. While clozapine can prolong QTc, this is not an absolute contraindication—use clinical judgment and consider baseline ECG monitoring.

  • Constipation: Clozapine causes severe constipation and gastrointestinal hypomotility 10. Mirtazapine's anticholinergic effects may worsen this. Implement prophylactic laxative regimens (docusate, senna, macrogols) 10.

Dosing Recommendations

Standard mirtazapine dosing when added to clozapine is 30 mg daily at bedtime 2, 4, 11. This dose was used in most efficacy trials. Start at 7.5-15 mg in elderly or frail patients 6.

Continue clozapine at its established therapeutic dose. No dose adjustment of clozapine is needed when adding mirtazapine 2.

Important Caveats

  • The evidence base consists primarily of small studies with short durations (6-8 weeks) 11, 12. Larger, longer-term trials are needed.

  • Most benefit appears in negative symptoms and cognition rather than positive symptoms 3, 4, 11.

  • This is an augmentation strategy for patients already stabilized on clozapine, not a first-line approach 12.

  • Avoid combining mirtazapine with MAOIs (contraindicated) and use caution with other serotonergic drugs due to serotonin syndrome risk 1.

References

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Guideline

pharmacological management of obesity: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2015

Related Questions

Is taking 30 mg of mirtazapine at bedtime together with 50 mg of quetiapine (Seroquel) likely to cause excessive sedation?
Is it safe to prescribe acetazolamide together with mirtazapine?
Are there any concerns or special considerations when prescribing mirtazapine (Remeron) to Asian patients?
What time of day should I give mirtazapine to my dog to stimulate appetite?
In an 85-year-old woman taking mirtazapine (Remeron) 30 mg nightly who has sundowning, should the dose be increased and what alternative or adjunctive treatment options are appropriate?
How should caloric weakness in a central vestibular deficit be evaluated and managed?
What functional‑medicine protocol should be employed to manage vertigo in an adult after serious organic causes such as vestibular neuritis, stroke, Meniere’s disease, acoustic neuroma, or medication‑induced toxicity have been excluded?
What causes a sensation of wetness in the external auditory canal when lying supine without recent water exposure?
What is the appropriate diagnostic work‑up and treatment plan for a 5‑year‑old male with an absent recto‑anal inhibitory reflex on anorectal manometry and a lifelong history of failure to pass stool?
In a patient with retinal hemorrhage presenting with chest pain and elevated troponin, is it appropriate to initiate a continuous heparin infusion?
What is the recommended dosage regimen for procainamide, including IV loading dose, maintenance infusion, oral dosing, and adjustments for severe renal impairment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.